All Pharmaceuticals articles – Page 2
-
Blog
PharmaEssentia appoints legal head
PharmaEssentia USA announced the appointment of Beth Krewson as head of legal.
-
Blog
HanAll Biopharma appoints legal chief
HanAll Biopharma announced the appointment of Christopher Slavinsky as chief business development and legal officer.
-
News Brief
DOJ orders DaVita to pay $34M over alleged dialysis center kickback scheme
DaVita, a multi-state dialysis provider, agreed to pay more than $34 million to resolve allegations it engaged in numerous kickback schemes to doctors who referred Medicare patients to its dialysis centers, the Department of Justice announced.
-
News Brief
Rite Aid reaches $410M settlement with DOJ in opioid false claims case
Rite Aid agreed to pay $7.5 million and allow the Department of Justice to access nearly $402 million from the company’s forthcoming bankruptcy case to settle allegations it helped fuel the nation’s opioid epidemic.
-
Blog
AVITA Medical appoints legal, compliance chief
AVITA Medical announced the appointment of Nicole Linda Kelsey as chief legal and compliance officer and corporate secretary.
-
Blog
OnKure appoints general counsel
Biopharmaceutical company OnKure announced the appointment of Rogan Nunn as general counsel and secretary.
-
Blog
Kriya appoints chief legal officer
Biopharmaceutical company Kriya Therapeutics announced the appointment of Katherine Eade to the position of chief legal officer.
-
News Brief
OFAC sanctions drug cartel over China procurement; FinCEN issues advisory
The Treasury Department’s Office of Foreign Assets Control and Secretary Janet Yellen announced sanctions Thursday against the top leaders of La Nueva Familia Michoacana drug cartel over the illicit trafficking of synthetic opioid fentanyl in the United States.
-
Blog
Seaport Therapeutics appoints general counsel
Biopharmaceutical company Seaport Therapeutics announced the appointment of Lana Gladstein as general counsel.
-
Blog
Contineum Therapeutics announces general counsel
Contineum Therapeutics announced the appointment of John Healy as general counsel and corporate secretary.
-
Blog
Alkeus Pharmaceuticals appoints legal chief
Alkeus Pharmaceuticals announced that Eric Trachtenberg has joined the company as chief legal officer.
-
Blog
Eli Lilly announces chief ethics and compliance officer retirement
Pharmaceuticals giant Eli Lilly and Company announced Alonzo Weems, executive vice president of enterprise risk management and chief ethics and compliance officer, will retire after 27 years of service with the company.
-
Blog
Enanta Pharmaceuticals announces legal chief
Enanta Pharmaceuticals announced the appointment of Matthew Kowalsky as chief legal officer.
-
News Brief
DOJ lawsuit charges Regeneron with inflating Medicare costs
New York-based Regeneron Pharmaceuticals is being sued by the Department of Justice for allegedly flouting Medicare’s price reporting requirements.
-
Blog
Rocket Pharmaceuticals appoints general counsel
Rocket Pharmaceuticals announced Martin Wilson was appointed general counsel and chief corporate officer.
-
Blog
SIGA Technologies names general counsel
SIGA Technologies, a commercial-stage pharmaceutical company focused on health security and infectious diseases, announced the appointment of Larry Miller as general counsel.
-
Blog
Elanco appoints new general counsel
Pharmaceutical company Elanco Animal Health announced the appointment of Shiv O’Neill as executive vice president, general counsel and corporate secretary.
-
Blog
YS Biopharma adds Juventas general counsel to board
YS Biopharma announced the appointment of Yuntao Cui, senior vice president and general counsel at Juventas Cell Therapy, to its board of directors.
-
Blog
Viridian Therapeutics appoints legal chief
Biopharmaceutical company Viridian Therapeutics announced the appointment of Jennifer Tousignant as chief legal officer.
-
News Brief
Zoetis says no action from OFAC in Iran sanctions matter
Zoetis, a developer and manufacturer of vaccines and medicines for animals, disclosed it was informed by the Office of Foreign Assets Control that it won’t face enforcement for potential violations of Iran sanctions uncovered during an acquisition integration.